proprietary product

proprietary product,

n any medicinal or herbal preparation whose formulation is owned exclusively by an individual or business.
References in periodicals archive ?
Several steps should be taken by the military to prevent the further escalation of proprietary product use and the problems that could result--
Under terms of a proprietary product development funding pact, DuPont will invest up to $45 million to support development of three proprietary products at Barr: CyPat, a prostate cancer therapy; Seasonale, an oral contraceptive; and an undisclosed third product.
Importantly, this agreement also helps balance our drug development portfolio across proprietary product candidates, fully funded programs, and co-development projects.
Critical to our decision making is solid evidence of a competitively advantaged, strong and proprietary product that meets an unmet or underserved need in a large and growing market," says CentriCap Manager & Principal, Jeff Brodlieb, adding, "and of course, there must be a strong management team capable of implementing and managing an accelerated growth strategy.
In addition, some generics companies are now involved in proprietary product research and development or in-licensing.
We tasked our development team to formulate a unique, proprietary product which uses high quality, pharmaceutical-grade ingredients backed by substantial peer-reviewed, published scientific research supporting their positive health benefits and efficacy addressing the problems associated with heart disease.
The Company's lead proprietary product candidate, VIVITROL(TM) (naltrexone for extended-release injectable suspension), is being developed as a once-monthly injection for the treatment of alcohol dependence.
Value-added, proprietary products are the only ones that typically makes serious money for companies.
Along with duck decoys, floral containers, and tackle boxes, these proprietary products generate 30% of the company's $350 million annual revenue.
Nasdaq: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies and neurovascular disease, noted that in the past two months three new peer-reviewed journal articles have been published covering various aspects of the NC-stat System, providing further validation for the utility and accuracy of conventional nerve conduction studies performed with the NC-stat System.
NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the Ninth Annual Growth Conference of Needham & Company, LLC at The New York Palace Hotel in New York City at 3:30pm (EST) on Thursday, January 11, 2007.
Nasdaq: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, including diabetic peripheral neuropathy, announced today that it has signed an exclusive licensing agreement with EyeTel Imaging, Inc.